http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CZ-298224-B6

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9640e15f6c2fc496bbfe6c5b34aa9110
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
filingDate 2003-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3d4910ef406c3052277bc62f0168cc8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f03b44bd1995266f7d07f514b690052
publicationDate 2007-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CZ-298224-B6
titleOfInvention A pharmaceutical composition comprising ribavirin as an active ingredient and a method for producing it
abstract A pharmaceutical composition comprising, as an active ingredient, ribavirin in admixture with at least one pharmaceutically acceptable excipient, which consists of a free-flowing granulate prepared by wet granulating a water-moistened ribavirin mixture, at least one water-insoluble pharmaceutically acceptable filler selected from the group consisting of: including metal carbonates, phosphates, sulfates, and silicates, and optionally at least one other pharmaceutically acceptable excipient, as well as a process for making the composition.
priorityDate 2003-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9609056-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1364643-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002161020-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9716173-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02074317-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24441
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452135712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID37542
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507729
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24456
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448897384
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62223
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453754419

Total number of triples: 32.